References
- National Institute of Health . What is Precision Medicine? (2020). https://ghr.nlm.nih.gov/primer/precisionmedicine/definition
- Watanabe J , McInnisT , HirschJ. Cost of prescription drug-related morbidity and mortality. Ann. Pharmacother.52, 829–837 (2018).
- Zdanowicz MM . Concepts in Pharmacogenomics: Fundamentals and Therapeutic Applications in Personalized Medicine. (2nd Edition). American Society of Health-System Pharmacists, MD, USA (2017).
- National Institute of Health – US National Library of Medicine . Genomics and Medicine. (2020). www.genome.gov/health/Genomics-and-Medicine#:∼:text=Genomic%20medicine%20is%20an%20emerging,implications%20of%20that%20clinical%20use
- Mayo Clinic . Patient care and health information – testing and procedures – genetic testing (2020). www.mayoclinic.org/tests-procedures/genetic-testing/about/pac-20384827
- Abacan M , AlsubaleL , Barlow-StewartKet al. The global state of the genetic counseling profession. Eur. J. Hum. Genet.27, 183–197 (2019).
- Choy N . Grey Genetics. How to become a genetic counselor (2019). www.greygenetics.com/howtobecome-a-genetic-counselor/
- Accreditation Council for Genetic Counseling . Practice-based competencies for genetic counselors (2015). www.gceducation.org/wp-content/uploads/2019/02/ACGC-Core-Competencies-Brochure_15_Web.pdf
- Roederer M , KuoG , KisorDet al. pharmacogenomics competencies in pharmacy practice: a blueprint for change. J. Am. Pharm. Assoc.57(1), 120–125 (2017).
- National Institute of Health . Genetics/genomics competency center (2020). https://genomicseducation.net/about
- US Bureau of Labor Statistics . Occupational Outlook Handbook (2020). www.bls.gov/ooh/
- Haga S , MoaddebJ. Pharmacogenomics courses in pharmacy school curricula. Pharmacogenomics20(9), 625–630 (2019).
- Clinical Pharmacogenetics Implementation Consortium (CPIC) (2021). https://cpicpgx.org/
- Whirl-Carrillo M , McDonaghEM , HebertJMet al. Pharmacogenomics knowledge for personalized medicine. Clin. Pharmacol. Ther.92(4), 414–417 (2012).
- FDA – US Food and Drug Administration . Table of Pharmacogenetic Associations (2020). www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations
- Johns Hopkins University . Online mendelian inheritance in man (OMIM) (1966–2021). https://www.omim.org/
- Cystic Fibrosis Foundation (2020). www.cff.org/What-is-CF/Genetics/Types-of-CFTR-Mutations/
- US National Library of Medicine: Genetics Home Reference. CTFR gene (2020). https://ghr.nlm.nih.gov/gene/CFTR
- Lopes-Pacheco M . CFTR modulators: the changing face of cystic fibrosis in the era of precision medicine. Front. Pharmacol.10, 1662 (2019).
- Burgener E , MossR. Cystic fibrosis transmembrane conductance regulator modulators: precision medicine in cystic fibrosis. Curr. Opin. Pediatr.30(3), 372–377 (2018).
- Vertex Pharmaceuticals Incorporated . Kalydeco (ivacaftor) tablets label (2012). www.accessdata.fda.gov/drugsatfda_docs/label/2012/203188lbl.pdf
- National Institute of Health: Genetic and Rare Diseases Information Center. Stevens-Johnson Syndrome/toxic Epidermal Necrolysis (2018). https://rarediseases.info.nih.gov/diseases/7700/stevens-johnson-syndrometoxic-epidermal-necrolysis
- Sylvia LM . Drug Allergy. In: Pharmacotherapy: A Pathophysiological Approach (10th Edition). McGraw-Hill, NY, USA (2017).
- FDA – US Food and Drug Administration . FDA Approved Drugs (2018). www.accessdata.fda.gov/drugsatfda_docs/label/2018/016084s044lbl.pdf
- Table of Pharmacogenomic Biomarkers in Drug Labeling. US Food and Drug Administration (2020). www.fda.gov/drugs/science-and-research-drugs/table-pharmacogenomic-biomarkers-drug-labeling
- US National Library of Medicine: Genetics Home Reference. MTHFR Gene (2020). https://ghr.nlm.nih.gov/gene/MTHFR
- US National Library of Medicine: Genetics Home Reference. Homocystinuria (2020). https://ghr.nlm.nih.gov/condition/homocystinuria#inheritance
- US National Library of Medicine: Genetics Home Reference. Factor V Leiden Thrombophilia (2020). https://ghr.nlm.nih.gov/condition/factor-v-leiden-thrombophilia#resources
- US National Library of Medicine: Genetics Home Reference. Prothrombin thrombophilia (2020). https://ghr.nlm.nih.gov/condition/prothrombin-thrombophilia#synonyms
- Novartis Pharmaceuticals Corporation . Promacta (2008). www.novartis.us/sites/www.novartis.us/files/promacta.pdf
- US National Library of Medicine: Genetics Home Reference. APOE Gene (2020) https://ghr.nlm.nih.gov/gene/APOE#conditions
- National Institute of Health: Genetic and Rare Diseases Information Center. Hyperlipidemia Type III (2016) https://rarediseases.info.nih.gov/diseases/6703/hyperlipidemia-type-3
- US National Library of Medicine: Genetics Home Reference. Breast Cancer (2020). https://ghr.nlm.nih.gov/condition/breast-cancer
- Kalia S , AdelmanK , BaleSet al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet. Med.19, 249–255 (2017).
- Hickey S , CurryC , TorielloH. ACMG practice guideline: lack of evidence for MTHFR polymorphism testing. Genet. Med.15(2), 153–156 (2013).
- Zhang S , TaylorAK , HuangXet al. Venous thromboembolism laboratory testing (factor V leiden and factor II c.*97G >A), 2018 update: a technical standard of the American College of Medical Genetics and Genomics (ACMG). Genet. Med.20(12), 1489–1498 (2018).
- Farrer L , BrinM , ElsasLet al. Members of the ACMG/ASHG Working Group on ApoE testing in Alzheimer disease. use of apolipoprotein E testing for Alzheimer disease. JAMA274, 1627–1629 (1995).
- Pal T , AgneseD , DalyMet al. Points to consider: is there evidence to support BRCA1/2 and other inherited breast cancer genetic testing for all breast cancer patients? A statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med.22, 681–685 (2020).
- National Institute of Health . ClinGen (2018). https://clinicalgenome.org/